Interestingly, IGFBP2 has been implicated as a candidate diagnostic for heart failure with a high sensitivity and specificity by urine proteomic analyses59, clearly highlighting its use as a potential biomarker for melanoma MAPKi resistance. Here, IGFBP2 is linked to melanoma.